18.6 Catheter associated urinary tract infection (CAUTI)
| Type of Infection | First Line (with Dosage and Duration) |
Alternative First Line (with dosage and Duration) |
Comments |
|---|---|---|---|
| CAUTI- not severely ill | Fosfomycin 3g stat PO Await culture, remove catheter if possible | Amikacin 15 mg/kg single dose | All hospital onset infections; should be managed as per hospital antibiograms; these recommendations are general and especially for places where there is no antibiogram (it is highly recommended to generate antibiograms). Target antibiotics as per culture reports Duration: 3-5 days (if catheter removed/changed) |
For common etiological agents of Catheter associated urinary tract infection (CAUTI), see Annexure B.18.6
Additional Information
- Catheter colonization is common and in absence of symptoms does not require treatment.
- Removal of indwelling catheter is recommended.
References
1. Soman R, Veeraraghavan B, Hegde A, Varma S, Todi S, Singh RK, Nagavekar V, Rodrigues C, Swaminathan S, Ramsubramanian V, Ansari A, Chaudhry D, Pednekar A, Bhagat S, Patil S, Barkate H. Indian consensus on the managemeNt of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II). Expert Rev Anti Infect Ther. 2024 Jun;22(6):453-468. doi: 10.1080/14787210.2024.2360116. Epub 2024 May 27. Erratum in: Expert Rev Anti Infect Ther. 2024 Jul;22(7):607. doi: 10.1080/14787210.2024.2370086. PMID: 38790080.
2. Guidance on Diagnosis & Management of Carbapenem Resistant Gram-negative Infections. ICMR. 2022. Available from: https://www.icmr.gov.in/icmrobject/custom_data/pdf/resource- guidelines/Diagnosis_and_management_of_CROs.pdf
3. Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CAUTI] and Non-Catheter- Associated Urinary Tract Infection [UTI]) Events. NHSN, CDC. 2025. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/7psccauticurrent.pdf
4. Mathur P, Malpiedi P, Walia K, Srikantiah P, Gupta S, Lohiya A, Chakrabarti A, Ray P, Biswal M, Taneja N, Rupali P, Balaji V, Rodrigues C, Lakshmi Nag V, Tak V, Venkatesh V, Mukhopadhyay C, Deotale V, Padmaja K, Wattal C, Bhattacharya S, Karuna T, Behera B, Singh S, Nath R, Ray R, Baveja S, Fomda BA, Sulochana Devi K, Das P, Khandelwal N, Verma P, Bhattacharyya P, Gaind R, Kapoor L, Gupta N, Sharma A, VanderEnde D, Siromany V, Laserson K, Guleria R; Indian Healthcare Associated Infection Surveillance Network collaborators. Health-care-associated bloodstream and urinary tract infections in a network of hospitals in India: a multicentre, hospital-based, prospective surveillance study. Lancet Glob Health. 2022 Sep;10(9):e1317- e1325. doi: 10.1016/S2214-109X(22)00274-1. PMID: 35961355.